NCT02914509 Phase 3 Study Evaluating Safety and Efficacy of OTX-TP in Subjects With OAG or OHT Status COMPLETED Phase PHASE3
NCT02891317 Assessing Ocular Hemodynamic Response to Surgical Intervention in Glaucoma Status TERMINATED Phase N/A
NCT02874846 Nocturnal/Diurnal Intraocular Pressure-Lowering Effect of Netarsudil Ophthalmic Solution Status COMPLETED Phase PHASE2
NCT02863224 Advanced Glycation End Products as a Biomarker for Accelerated Ageing Status COMPLETED Phase N/A
NCT02858284 Evaluation of Safety and Efficacy of TUG (Therapeutic Ultrasound for Glaucoma) in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension Status TERMINATED Phase NA
NCT02801617 Non-inferiority of PRO-067 Ophthalmic Solution vs GAAP Ofteno® in Glaucoma or Ocular Hypertension Status TERMINATED Phase PHASE3
NCT02796560 Generic Travoprost Versus Brand Name Travoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE4
NCT02792803 A Comparison of Xalatan (Latanoprost) to Apo-latanoprost and Co-latanoprost in the Treatment of Glaucoma Status UNKNOWN Phase PHASE4
NCT02743780 A Three Part Study of MGV354 in Ocular Hypertension or Glaucoma Status COMPLETED Phase PHASE1/PHASE2
NCT02742649 A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE1/PHASE2
NCT02730871 Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV® Status TERMINATED Phase PHASE4
NCT02674854 Double-masked Study of PG324 Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE3
NCT02628223 180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma Status COMPLETED Phase NA
NCT02623738 A Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension -AYAME Study- Status COMPLETED Phase PHASE2/PHASE3
NCT02617459 Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE3
NCT02585375 Latanoprost Preserved Versus Unpreserved: Effect on Tear Film Thickness as Measured With OCT Status UNKNOWN Phase PHASE4